मैगज़्टर गोल्ड के साथ असीमित हो जाओ

मैगज़्टर गोल्ड के साथ असीमित हो जाओ

9,500 से अधिक पत्रिकाओं, समाचार पत्रों और प्रीमियम कहानियों तक असीमित पहुंच प्राप्त करें सिर्फ

$149.99
 
$74.99/वर्ष

कोशिश गोल्ड - मुक्त

THE RISE AND RISE OF AYUSH

Healthcare Radius

|

September 2023

The AYUSH sector has been experiencing significant growth in India. A focus on the trends in this sector, the demand drivers, and the way forward.

- NAGESH JOSHI

THE RISE AND RISE OF AYUSH

The phrase, 'a diamond in the rough' is an old Renaissance idiom that refers to something (or someone) with great potential but unimpressive at first glance. However, with the right refinement and exposure, it reveals its brilliance and mesmerizes others with its sparkling glory.

The ancient Indian treatments grouped today under the nomenclature of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homeopathy) present a similar tale of 'a diamond in the rough.' After staying low-profile for several decades after India's independence, the sector is exhibiting strong potential for recognition and growth.

According to a research report on the Ayush sector by the Forum on Indian Traditional Medicine (FITM) under Research and Information System for Developing Countries (RIS), the size of the Ayush market stood at $18.1 billion (Rs 1,49,451 crore) in 2020, growing from $2.85 billion (Rs 23,532 crore in 2014-15.

According to a report by the Research and Information. System for Developing Countries (RIS), 'Ayush Sector in India: Prospects & Challenges, the global market size of the herbal sector was about $657.5 billion (Rs 54,28,977 crore) in 2020. The total Ayush export of India has increased from $1.09 billion (Rs 9,000 crore) in 2014 to $1.54 billion (Rs 12,715 crore) in 2020. Another agency, Mordor Intelligence, estimates that the AYUSH industry in India is expected to reach Rs 1,82,400 crore by 2028, growing at an 8.6 percent CAGR from Rs 62,600 crore in 2022.

Role of the government

Healthcare Radius से और कहानियाँ

Healthcare Radius

Healthcare Radius

ASTER DM HEALTHCARE EXPANDS BENGALURU FOOTPRINT WITH RS 580 CRORE HOSPITAL

Aster DM Healthcare has announced an Rs 580 crore investment to develop a state-of-the-art, 500-bed multi-specialty hospital in Yeshwanthpur.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

COULD DONALD TRUMP'S TRADE MOVES HIT INDIA'S PHARMA EXPORTS NEXT?

If tariffs hit, medicines could cost more in the U.S., and India's drug industry could take a hit. For now, it's all talk, but India's pushing for trade deals and new markets to stay strong.

time to read

3 mins

September 2025

Healthcare Radius

Healthcare Radius

HCG TREATS 33-YR-OLD PATIENT WITH SCARLESS CANCER SURGERY

HCG Manavata Cancer Centre (HCGMCC) successfully performed a scarless intraoral surgery on a 33-year-old male diagnosed with buccal mucosa (cheek) cancer.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

CELCIUS LOGISTICS LAUNCHES PHARMA COLD CHAIN ARM WITH RS 50CR INVESTMENT

Celcius Logistics has announced the launch of Celcius+, a specialised logistics arm dedicated exclusively to the seamless management of the pharmaceutical supply chain.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

PFIZER LAUNCHES 20-VALENT PNEUMONIA VACCINE FOR ADULTS IN INDIA

Pfizer announced the launch of its nextgeneration 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

MANIPAL HOSPITAL APPOINTS DR. SURENDER DABAS TO LEAD ROBOTIC CANCER CARE IN DELHI

Manipal Hospital welcomes one of India's most renowned and celebrated robotic onco-surgeons, Dr. Surender Kumar Dabas, as Chairman – Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

ZYDUS RECEIVES USFDA APPROVAL FOR CONSTIPATION DRUG PRUCALOPRIDE

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Prucalopride Tablets, 1 mg and 2 mg (USRLD: Motegrity Ⓡ Tablets, 1mg and 2 mg).

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

SSI PERFORMS WORLD'S FIRST CARDIAC TELESURGERY ACROSS 10,000 KM

SS Innovations International, Inc. has achieved a historic milestone at the Annual Conference of the Society of Robotic Surgery (SRS) in Strasbourg, France, with the successful completion of two complex transcontinental robotic telesurgeries using the indigenously developed SSI Mantra Surgical Robotic System.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

MANIPAL HOSPITALS SIGNS MOU WITH MAHA GOVT TO INVEST RS 700CR IN NEW NAGPUR HOSPITAL

Manipal Hospitals has signed a Memorandum of Understanding (MoU) with the Government of Maharashtra to build a state-of-the-art 350-bed multi-speciality Hospital at Nagpur.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

INSIDE INDIA'S AMR CHALLENGE: FIXING AWARENESS, DIAGNOSTICS AND HOSPITAL POLICY GAPS

Dr. Narendra Saini of the IMA unpacks India's escalating AMR crisis, highlighting solutions to bridge awareness, diagnostics and policy gaps in the fight against a looming public health threat.

time to read

9 mins

September 2025

Translate

Share

-
+

Change font size